Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis"

Breast Cancer Res Treat. 2022 Aug;194(3):709-710. doi: 10.1007/s10549-022-06590-8. Epub 2022 Jun 24.

Francesca Poggio¹, Marcello Ceppi², Piero Fregatti^{3

4}, Matteo Lambertini^{5

6}, Marco Tagliamento⁷

¹ Medical Oncology 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
² Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
³ Department of Surgical Sciences and Integrated Diagnostic (DISC), School of Medicine, University of Genova, Genova, Italy.
⁴ Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
⁵ Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. matteo.lambertini@unige.it.
⁶ U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. matteo.lambertini@unige.it.
⁷ Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.

No abstract available

Publication types